X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercepharma.com/manufacturing/uk-enlists-csl-seqirus-standby-flu-pandemic-preparedness-shots-produced-liverpool#:~:text=Tuesday%2C%20the%20UK%20Health%20Security,next%20four%20years%2C%20CSL%20said.
https://www.prnewswire.com/news-releases/seqirus-begins-shipping-portfolio-of-innovative-influenza-vaccines-for-the-202223-us-season-301583651.html
https://www.prnewswire.com/news-releases/cdc-advisory-committee-includes-fluad-quadrivalent-as-a-preferentially-recommended-influenza-vaccine-for-adults-65-and-older-301573521.html
https://www.prnewswire.com/news-releases/seqirus-holly-springs-manufacturing-facility-designated-by-us-government-as-pandemic-ready-301560087.html
https://endpts.com/sanofi-petitions-fda-over-misleading-label-for-rival-flu-vaccine-that-failed-to-confirm-benefit/
https://www.prnewswire.com/news-releases/seqirus-and-us-government-renew-multi-year-agreement-for-influenza-pandemic-preparedness-and-response-301490505.html
https://www.prnewswire.com/news-releases/seqirus-announces-us-fda-approval-for-multi-dose-vial-presentation-of-first-ever-adjuvanted-cell-based-pandemic-influenza-vaccine-301430826.html
https://www.prnewswire.com/news-releases/seqirus-presents-new-real-world-evidence-supporting-effectiveness-of-differentiated-seasonal-influenza-vaccine-technologies-at-isirv-who-virtual-conference-2021-301403257.html
https://www.biospace.com/article/releases/seqirus-receives-fda-approval-of-its-cell-based-quadrivalent-influenza-vaccine-expanding-the-age-indication-to-include-children-as-young-as-six-months/?s=71
https://www.fiercepharma.com/pharma/recipe-for-disaster-sanofi-gsk-and-seqirus-prep-for-near-record-flu-shot-deliveries-as-delta
Market Place
Share 
